Post-Surgical Rehabilitation of Dupuytren's Disease: A Retrospective Study
DOI:
https://doi.org/10.25759/spmfr.252Keywords:
Dupuytren Contracture/rehabilitation, Postoperative CareAbstract
Introduction: Dupuytren’s disease is a benign proliferative connective tissue disorder that involves the hand’s palmar fascia. The first clinical signs reported by the patients are thickening near the MCP. The small finger is the most affected. Dupuytren’s disease is more common in men over 40 years old. Diabetes mellitus, alcohol use, smoking and HIV have all been associated with a higher risk of Dupuytren’s disease. Surgical intervention is the gold standard on Dupuytren’s treatment and is indicated in cases of advanced disease. Postoperative rehabilitation should start between 3 and 5 days with early range of motion and palmar shift.
Purpose: Characterize the post-operative population with Dupuytren’s disease and evaluate gains with the intervention of rehabilitation.
Method: Retrospective and descriptive longitudinal study using the clinical data of surgically treated patients with Dupuytren’s disease evaluated and treated according with a protocol of occupational therapy at our department. Results: From a total of 50 surgically treated patients, between January 2014 and August 2015, 92% were men. The average age was 64.22 years. Risk factors association was predominantly diabetes mellitus (22%), smoking (8%) and moderate to severe alcoholic habits (6%). A percentage of 54% were intervened in the right hand, and the majority of the patients were intervened in the 5th finger (38%). Forty two patients (84%) attended the sessions twice a week. Thirteen patients abandoned the treatment before the end. The treatment had an average length of 70.14 days (SD 42.5). In comparison between the beginning and the end of the rehabilitation program there were a significantly difference in the range of motion of the extension and flexion of the MCP (p = 0.00, p = 0.03) and PIP (p = 0.00, p = 0.01). Other statistical significant relations were not found
Discussion and Conclusion: Surgery followed by a structured rehabilitation program in Dupuytren’s disease allows an improvement in range of motion.
Downloads
References
Burge P. Genetics of Dupuytren’s disease. Hand Clin. 1999;15: 63-72.
Gudmundsson KG, Arngrimsson R, Sigfusson N, Bjornsson A, Jonsson T.
Epidemiology of Dupuytren’s disease:clinical, serological, and social
assessment. J Clin Epidemiol. 2000;53:291-6.
Karkampouna S, Kreulen M, Obdeijn MC, Kloen P, Dorjée, AL, Rivelles, F,
et al. Connective tissue degeneration: mechanisms of palmar fascia
degeneration (Dupuytren’s disease). Curr Mol Biol Rep. 2016;2:133-40.
Ross D. Epidemiology of Dupuytren’s disease. Hand Clin. 1999;15;53-62.
Saar JD, Grothaus PC. Dupuytren’s disease: an overview. Plast Reconstr
Surg. 2000;106:125-34.
Hart MG, Hooper G. Clinical associations of Dupuytren’s disease. Postgrad
Med J. 2005;81:425-8.
Murrell GA, Francis MJ, Bromley L. The collagen changes of Dupuytren’s
contracture. J Hand Surg Br. 1991;16:263-6.
McFarlane,RM, Botz FS, Cheung H. Dupuytren’s disease biology and
treatment. Edinburgh: Churchill Livingstone; 1990.
Lee H, Eo S, Cho S, Jones NF. The surgical release of Dupuytren’s
contracture using multiple transverse incisions. Arch Plast Surg.
;39;426-30.
Abe Y, Rokkaku T, Kuniyoshi K, Matsudo T, Yamada T. Clinical results of
dermofasciectomy for Dupuytren’s disease in Japanese patients. J Hand
Surg Eur Vol. 2007;32:407-10.
Dias JJ, Braybrooke J. Dupuytren’s contracture: an audit of the outcomes
of surgery. J Hand Surg Br. 2006;31:514-21.
Bayat A, McGrouther DA. Management of Dupuytren’s disease - clear
advice for an elusive condition. Ann R Coll Surg Engl. 2006;88:3-8.
Mullins PA. Postsurgical rehabilitation of Dupuytren’s disease. Hand Clin.
;15:167-74, viii.
Larson D, Jerosch-Herold C. Clinical effectiveness of post-operative
splinting after surgical release of Dupuytren’s contracture: a systematic
review. BMC Musculoskelet Disord. 2008 ;9:104.
Baird KS, Crossan JF, Ralston SH. Abnormal growth factor and cytokine
expression in Dupuytren’s contracture. J Clin Pathol. 1993;46:425-8.
Pratt AL, Ball C. What are we measuring? A critique of range of motion
methods currently in use for Dupuytren's disease and recommendations
for practice. BMC Musculoskelet Disord. 2016;17:20.
Eckerdal D, Nivestam A, Dahlin LB. Surgical treatment of Dupuytren’s
disease - outcome and health economy in relation to smoking and
diabetes. BMC Musculoskelet Disord. 2014;15:117.
Henry M. Dupuytren’s disease: current state of the art. Hand. 2014;9:1-8.
Downloads
How to Cite
Issue
Section
License
Copyright statement
Authors must also submit a copyright statement (as seen below) on article submission.
To the Editor-in-chief of the SPMFR Journal:
The below signed author(s) hereby state that the article
________________________________________ (ref. MFR_________) is
an original unpublished work and all facts stated are a product of the author(s) investigation. This article does not violate any copyright laws or privacy statements. The author(s) also hereby confirm that there is no conflict of interest's issues in this article.
By submitting this article the author(s) agree that after publication all copyrights belong to the SPMFR Journal.
Signed by all authors
Date:
Names (capital letters):
Signatures:
The SPMFR Journal’s contents are follow a Creative Commons licence. After publication the authors can hand out the articles as long as the SPMFR Journal is credited.
